Ferric chloride, an anomerization catalyst for the preparation of alkyl α-glycopyranosides

合集下载

有机化学中常见名词中英文对照

有机化学中常见名词中英文对照

有机化学中常见名词中英文对照英中对照abietic acid (松香酸)acetal(缩醛)acid anhydride(酸酐)A.Couper(古柏尔)acridine(吖啶)acronycine (山油柑碱)acidylating reaction(酰化反应)acyl group(酰基)acyl halide (酰卤)adenine(腺嘌呤)adrenal cortex hormone (肾上腺皮质激素) A.Kekule(开库勒)alanine(丙氨酸)alcoholysis(醇解)aldehyde(醛)alicyclic hydrocarbon(脂环烃)alizarin(茜草素)alizarin-type(茜素型)alkane(烷烃)alkene(烯烃)alkylation(傅-克烷基化反应)alkyne(炔烃)aloeemodin (芦荟大黄素)amines(胺类)amide(酰胺)amidino(脒基)amino acid(氨基酸)β-aminobutyric acid(β-氨基丁酸)ammonolysis(氨解)andiron formula(锯架式)andrographolide (穿心莲内酯)anisodine (樟柳碱)annulene(轮烯)anomer(异头物)anomeric effect(异头效应)anthocyanidin (花色素)anthraquinone (蒽醌)anthrol (蒽酚)anthrone (蒽酮)anthracene(蒽)antiaromaticity or antiaromatic compound(反芳香性化合物)apigenin (芹菜素)apple polyphenols (苹果多酚) aromatic compound(芳香性化合物)aromatic hydrocarbon(芳香烃)aromaticity(芳香性)aromatization(芳构化)arecoline (槟榔碱)arginine(精氨酸)aspartic acid(天冬氨酸)asymmetric carbon atom (手性碳原子) atomic orbital(原子轨道)A.Wurtz reaction(武兹反应)axial bond(直立键,a键)azulene)Baeyer(拜耳)baicalein (黄芩素)baicalin (黄芩苷)barbital(巴比妥)barbituric acid(巴比妥酸) base complementary(碱基配对) benzoimidazole(苯并咪唑)benzothiazole(苯并噻唑)benzene(苯)berberine (小檗碱)Berzelius(伯察留史)beta-pleated sheet( -折叠)bi-anthracene nucleus (双蒽核) biological methylate(生物甲基化)biuret reaction(缩二脲反应)σbond (σ键)πbond (π键)borneol (龙脑)Braun reaction (布朗反应)bridged hydrocarbon(桥环烃)bytrepob(布特力洛夫)camphor(樟脑)cardiac glycosides(强心苷) camptothecine (喜树碱)carotene (胡萝卜素)carthamin (红花苷)carbene(卡宾;碳烯)carbohydrate(碳水化合物)carbonyl (羰基)carboxyl(羧基)carboxylic acid(羧酸)cassiamine (山扁豆双醌)catechin (儿茶素)cellobiose(纤维二糖)cellulose(纤维素)cephalin(脑磷脂)chain carbon constitution(链状碳架)chain initiation step(链引发阶段)chain propagation step(链增长阶段)chain termination step(链终止阶段)chalcone (查尔酮)charge-transfer complex(电荷转移络合物)chemical bond(化学键)chemocholic acid(鹅去氧胆酸)chirality(手性)chitin(甲壳质)chitosamine(壳糖胺)chlorophyll(叶绿素)cholalic acid (胆甾酸)cholestane (胆甾烷)cholesterol (胆甾醇)chromatography(色谱法)chrysophanol 9-anthrone (9-蒽酮大黄酚)chrysarobin (柯桠素)cinchonine(金鸡宁)cis-trans isomer(顺反异构体)cistrans isomerism(顺反异构)citral(柠檬醛)Claisen rearrangement(克莱森重排)Claisen-Schmidt reaction(克莱森-斯密特反应)cocaine (古柯碱)codonopsine (党参碱)concerted reaction(协同反应)condensed nuclei hydrocarbon(稠环烃)conformation(构象)conformational isomerism(构象异构)coniine (毒芹碱)conjugated diene(共轭二烯烃)conjugation system (共轭体系)conjugative effect(共轭效应)conservation of orbital symmetry(分子轨道对称性守恒理论)constitutional isomerism (构造异构)coprostane (粪甾烷)cortisone (可的松)crown ether(冠醚)cumulative diene(聚集二烯烃)curcumenol (莪术醇)cyanidin (矢车菊素)cyclic carbon constitution(环状碳架)cycloaddition recation(环加成反应)cycloalkane (脂环烃)cyclodextrin(环糊精)cysteine(半胱氨酸)daidzein (大豆黄素)Darzens reaction(达尔森反应) decarboxylation(脱羧反应) delocaization(离域)delocalization energy(离域能) delocalized electron(离域电子)delocalized energy(离域能)delphinidin(飞燕草素)denature(变性)deoxyribonucleic acid(脱氧核糖核酸) derivative of carboxylic acid (羧酸衍生物) diastereoisomer(非对映体)diazotization reaction(重氮化反应)diazonium salt(重氮盐)diborane(乙硼烷)dichlorocarbene(二氯卡宾)β-dichroine (β-常山碱)Diels—Alder reaction(狄尔斯—阿尔德反应)diene(双烯体,二烯烃)dienophile(亲双烯体)dihydrochalcone (二氢查尔酮) β—dihydrotheelin (β—雌二醇)distillation(蒸馏法)diterpenoids (二萜类)effective atomic number(有效原子序数)E.J.Cory—H.House reaction(科瑞—郝思反应)electric field scan(电场扫描)18-electron rule(18电子规则)electromeric effect(电性效应)electrophilic addition(亲电加成反应)electrophilic substitution(亲电取代)electrophile(亲电性试剂)elimination reaction(消除反应)Emde degradation (埃姆德降解)1-emetine(1-吐根碱)emodin-type (大黄素型)enantiomerism(对映异构)enantiomer(对映体)end-group effect(端基效应)entgegen(E,相反之意)energy of activation(活化能)enzyme(酶)ephedrine (麻黄碱)epicatechin (表儿茶素)epicatechin gallate(表儿茶素没食子酸酯) epigallocatechin (表没食子儿茶素)epigallocatechin gallate (表没食子儿茶素,没食子酸酯) epimer(差向异构体)epoxidation(环氧化反应)equatorial bond(平伏键,e键)ergometrine(麦角新碱)ergostenol (麦角甾醇)essential amino acid(必需氨基酸)essential fatty acid(必需脂肪酸)ester(酯)esterification(酯化反应)extraction(萃取法)farnesol (金合欢醇)fatty acid(脂肪酸)Fischer projection formula(费歇尔投影式)flavanol (黄烷醇)flavanone (二氢黄酮)flavanonol (二氢黄酮醇)flavonoid (黄酮)flavonol (黄酮醇)formalin(福尔马林)free radical (自由基)free radical chain reaction (自由基链反应) Freon (氟利昂)Friedel-Crafts reaction (傅瑞德尔-克拉夫兹反应) reagent ( 试剂 )frontier orbital (前线轨道理论)fructose (果糖)fucose (海藻糖)furan (呋喃)fused ring carbon constitution (稠环碳架) F.Wohler (武勒)Gabreil reaction (盖布瑞尔合成法)galactose (半乳糖) ..Frohde ..Frohdegallocatechin (没食子儿茶素)gallocatechin gallate (没食子儿茶素没食子酸酯) Gattermann-Koch reaction(盖特曼-科希反应)geometricalisomer(几何异构体)germacrone (杜鹃酮)glucose(葡萄糖)glutamic acid(谷氨酸)glutamine(谷酰胺)glycerol(甘油)glycocholic acid (甘氨胆酸)glycogen(糖原)glycoside(糖苷)glycyrrhizic acid (甘草酸)glycyrrhetinicacid (甘草次酸)Gmelin(哥美林)green tea polyphenols(绿茶多酚)Grignard Reaction(格氏反应)Grignard Reagent(格林那试剂,格氏试剂)G.Schiemann reaction(希曼反应)guaiazulene (愈创木奥)guanidine(胍)guanidino (胍基)guanine(鸟嘌呤)guanyl (脒基)haloform(卤仿)halogenation(卤代反应)halogenation reaction(卤化反应)Haworth(哈沃斯)heat of hydrogenation(氢化热)heat of reaction(反应热)hemiacetal(半缩醛)hesperetin (橙皮素)Hinsberg reaction(兴斯堡反应)histidine(组氨酸)H.Kolbe(科尔贝)Hoffmann degradation(霍夫曼降解反应)Hoffmann elimination(霍夫曼消除)Hoffmann exhaustive methylation(霍夫曼彻底甲基化反应)HOMO(Highest Occupied Molecnlar Orbital,最高被占用分子轨道) homolog(同系物)homologous series(同系列)hormone (激素)Hückel rule(休克尔规则)hybrid orbital(杂化轨道)hydroboration(硼氢化反应)hydrocortisone (氢化可的松) hydrogen bond(氢键)hydrolysis(水解)hyoscyamine (莨菪碱) hyperconjugation effect(超共轭效应)imidazole(咪唑)inclusion compound(包含物)indole(吲哚)inductive effect(诱导效应)infrared spectroscopy(红外光谱)insulin(胰岛素)invert sugar(转化糖)iodine number(碘值)tectoridin (鸢尾苷)isoelectric point(PI,等电点)isoflavanone (二氢异黄酮)isoflavone (异黄酮)isolated diene(隔离二烯烃)isoleucine(异亮氨酸)isoliquiritigenin (异甘草素)isomer(同分异构体)isoquinoline(异喹啉)isorhamnetin (异鼠李素) isorhynchophylline (异钩藤碱)isothiazole(异噻唑)isoxazole(异噁唑)Jones reagent(琼斯试剂)ketal(缩酮)ketone(酮)K.fries rearrangement(傅瑞斯重排)K.Fukui (福井谦一)Knoevenagel reaction(克脑文盖尔反应)Kolbe-Schmidt reaction(柯尔柏-施密特反应)Kutchcrov reaction(库切洛夫反应)lactose(乳糖)lecithin(卵磷脂)leptosidin (莱普西汀)leucine(亮氨酸)leucocyanidin (无色矢车菊素)limonene (苧烯)Lindlar(林德拉)liquiritin (甘草苷)lithium methide(甲基锂)lobeline (山梗菜碱)Lucas reagent(卢卡斯试剂)LUMO(Lowest Unoccupied Molecular Orbital)最低空余分子轨道lupinine (羽扇豆碱)lycopene (番茄红素)lycopodine (石松碱)lysine(赖氨酸)maackiain (高丽槐素)Macquis reagent (Macquis试剂)macrophylline (大叶千里光碱)magnesium acetate reaction (醋酸镁反应)magnetic field scan(磁场扫描)malonyl urea(丙二酰脲)maltose(麦芽糖)Mannich reaction(满尼希反应)mannose(甘露糖)mass spectroscopy(质谱)matrine (苦参碱)M. Besthelot(佰赛儒)Mclafferty(麦可拉费蒂重排)(-)-melacacidin [(-)黑金合欢素]menthol(薄荷醇)(±)-menthol [(±)-薄荷醇] menthone (薄荷酮)mesomer (内消旋体)methionine(蛋氨酸)methylporgestin (甲孕酮)provera(甲孕酮)methyltestosterone (甲基睾丸素) molecular orbital(分子轨道)molecular orbital theory(分子轨道理论)monoanthracene nucleus (单蒽核) monocrotaline (一野百合碱)monomer(单体)monoterpenoids (单萜) monosaccharide(单糖)morphine (吗啡)mutarotation(变旋光现象)naphthalene(萘)narcotine (那可汀)natrium amalgam reaction (钠汞齐反应) (±)-neomenthol [(±)-新薄荷醇] nerol (橙花醇)Newman projection(纽曼投影式)Newman projection formula(纽曼投影式)Nicol prism(尼科尔棱镜)nicotine (烟碱)ninhydrin(茚三酮)nitration(硝化反应)nitro compound(硝基化合物)nonaromatic compound(非芳香性化合物)nonbenzenoid hydrocarbon(非苯芳烃)nuclear magnetic resonance spectroscopy(核磁共振谱)nucleic acid(核酸)nucleophilic addition(亲核加成反应)nucleophilic reagent(亲核试剂)nucleoside(核苷)nucleotide(核苷酸)ocimene (罗勒烯)oligosaccharide(寡糖)frontier orbital (前线轨道理论)Oppenaner oxidizing reaction(欧芬脑尔氧化)optical isomer (旋光异构体)optical rotation instrument(旋光仪)organometallic compound(有机金属化合物)organometallics (金属有机化合物)orientation rule (定位规则)oxanthranol (氧化蒽酚)oxazole (噁唑)oxidation number (氧化值)oxidation state (氧化态)盐) oxonium salt oxymatrine (氧化苦参碱)palmatine (巴马汀)papaverine (罂粟碱)paraffin (烷烃)pelargonidin(天竺葵素)peptide (肽)peptide bond (肽键)peptide linkage(肽键)pericyclic reaction (周环反应)Perkin reaction (柏金反应)permeation (透析法)peroxide (过氧化物)peroxide effect (过氧化物效应)phellamurin (黄柏素-7-O-葡萄糖苷) phenanthrene (菲)phenylalanine (苯丙氨酸)phosphorus ylide(膦叶立德)phylloxanthin (叶黄素)physostigmine (毒扁豆碱)pinacol(频哪醇)pinene (蒎烯)piperine (胡椒碱)plane polarized light (平面偏振光) polycyclic aromatic hydrocarbon(多环芳烃)polymer(聚合物)polynuclear aromatic compound(稠环芳烃)polypeptide(多肽)polyreaction(聚合反应)polysaccharide(多糖)polytetrafluroethyleney(泰氟隆)unsaturated fatty acid(不饱和脂肪酸) precipitation(沉淀法)primary structure(一级结构)proanthocyanidin (原花色素) progesterone (黄体酮)protein(蛋白质)pseudoephedrine (伪麻黄碱)pteridine(蝶啶)purine(嘌呤)pyran(吡喃)pyrazine(吡嗪)pyrazole(吡唑)pyridazine(哒嗪)pyridine(吡啶)pyrimidine(嘧啶)pyrrole(吡咯)quaternary structure(四级结构)quercetin (槲皮素)quinine (奎宁)quinoline(喹啉)quinones(醌)racemic mixture(外消旋体)racemization(外消旋化)rancidity(酸败)Raney Ni(兰尼镍)reaction mechanism(反应历程)Reimer-Tiemann reaction(瑞穆尔-蒂曼反应)reserpine (利血平)residue(残基)resonance energy(共振能)resonance hybrid(共振杂化体)resonance theory(共振论)resonating structure(共振结构式)resveratrol (白藜芦醇)R.B.Woodward(伍德沃德)rhein (大黄酸)R.Hoffmann (霍夫曼)rhynchophylline (钩藤碱)ribonucleic acid(核糖核酸)ribose(核糖)rotation (旋光度)rutin (芦丁)saccharide(糖类)Sandmeyer-Gattermann reaction(桑得迈尔—盖特曼反应)Sandmeyer reaction(桑得迈尔反应)saponification(皂化)saponification number(皂化值)Sarrett reagent(沙瑞特试剂)Sawhares projection(萨哈斯投影式)sawhorse projection formula(锯架式)Schiff’s base(西佛碱)secondary structure(二级结构)securinine (一叶萩碱)sennoside A、B、C、D (番泻苷A、B、C、D) serine(丝氨酸)sesquiterpenoids (倍半萜)sigmatropic reaction(σ键迁移反应)silane(硅烷)single bond(单键)sinoacutine (清风藤碱)β—sitosterol (β—谷甾醇)skyrin (天精,醌茜素)S N(Nucleophilic substitution)(亲核取代)S N1(单分子亲核取代反应)S N2 (双分子亲核取代反sodium borohydride reaction (四氢硼钠反应) sparteine (金雀花碱)specific rotation (比旋光度)sphingomyelin(鞘磷脂)spiro hydrocarbon(螺环烃)squalene (鲨烯)stachydrine (水苏碱)starch(淀粉)stereochemistry (立体化学)stereoisomer(立体异构)stereocpecificity (立体专一性)steroidal compound (甾体化合物)Stevens rearrangement(史蒂文斯重排)stigmastane (豆甾烷)strychnine (士的宁)sucrose(蔗糖)sulfonation(磺化反应)systematic nomenclature(系统命名法)taurocholic acid (牛磺胆酸)tautomer(互变异构体)tautomerism(互变异构现象)taxifolin (黄杉素)tea polyphenols(茶多酚)Teflon (泰氟隆)terpenoid (萜类化合物)tertiary structure(三级结构)testosterone (睾丸素)tetrahydropalmatine (延胡索乙素, 四氢巴马汀) tetramethyl silane(四甲基硅烷)tetraterpenoid(四萜类)thiazole(噻唑)thiophene(噻吩)threonine(苏氨酸)torsional energy(扭转能)torsional strain(扭转张力)transition sate(过渡态)triglyceride(甘油三酯)trimethyl aluminium(三甲基铝)triptolide (雷公藤甲素)triterpenoid(三萜类)tryptophan(色氨酸)tylophorinine (娃儿藤定碱)tyrosine(酪氨酸)uridine(尿嘧啶)urea(脲)urotropine(乌洛托品)valence bond method(价键学说)valine(缬氨酸)visible-ultraviolet spectroscopy(可见-紫外光谱)vitamin A(维生素A)vitamin B12(维生素B12)Wilkinson (威尔克森)Williamson synthesis(威廉森合成法)Wittig reaction(维蒂希反应)zingiberene (姜烯)Zusammen(Z,德文,在一起之意)中英对照1 A1A 反应历程(1A1Areaction mechanism )吖啶(acridine)埃姆德降解(Emde degradation)安息香缩合反应(benzoic condensation reaction)氨基酸(amino acid)β-氨基丁酸(β-aminobutyric acid)氨解(ammonolysis)胺(amines)azulene)2 BAC 反应历程(2BACreaction mechanism )巴比妥(barbital)巴马汀(palmatine)白藜芦醇(resveratrol)拜耳(Baeyer)佰赛儒(M. Besthelot)半缩醛(semiacetal )半胱氨酸(cysteine)半乳糖(galactose)包含物(inclusion compound)苯丙氨酸(phenylalanine)苯(benzene)苯甲酸(benzoic acid)苯二甲酸(benzene dicarboxylic acid)苯并咪唑(benzimidazole)苯并噻唑(benzothiazole)倍半萜(sesquiterpenoid)比旋光度(specific rotation)必需氨基酸(essential amino acid)变性(denature)变旋光现象(mutarotation)表儿茶素(epicatechin)表儿茶素没食子酸酯(epicatechin gallate)表没食子儿茶素(epigallocatechin)表没食子儿茶素没食子酸酯(epigallocatechin gallate) 表面活性剂(surface active agent )槟榔碱(arecoline)丙氨酸(alanine)丙氨酸乙硫酯(ethyl alanine sulfide)丙二酰脲 (malonyl urea)伯察留史(Berzelius)柏金(Perkin)反应薄荷醇(menthol)(±)—薄荷醇((±)—menthol)薄荷酮(menthone)布特力洛夫(Bytrepob)布朗反应(Braun reaction)残基(residue)草酸(oxalic acid)超共轭效应(hyperconjugation effect)差向异构体(epimer)查尔酮(chalcone)茶多酚(tea polyphenols)β-常山碱(β-dichroine)沉淀法(precipitation)橙皮素(hesperetin)橙花醇(nerol)稠环芳烃(polynuclear aromatic compound)稠环碳架(fused ring carbon constitution)醇钠(sodium alcohols)醇解(alcoholysis)穿心莲内酯(andrographolide)磁场扫描(magnetic field scan)β—雌二醇(β—dihydrotheelin)醋酸镁反应(magnesium acetate reaction )萃取法(extraction)DDQ(2,3-二氯-5,6-氰基-1,4-苯醌)大黄素型(emodin-type)大黄酸(rhein)大豆黄素(daidzein)大叶千里光碱(macrophylline)达尔森(Darzen)反应哒嗪(pyridazine)单键(single bond)单体(monomer)单蒽核(monoanthracene nucleus)单萜(monoterpenoids)单糖(monosaccharide)单线态(singlet)蛋氨酸(methionine)蛋白质(protein)胆甾烷(cholestane)胆甾醇(cholesterol)胆甾酸(cholalic acid)胆甾烷(cholestane)胆甾醇(cholesterol)党参碱(codonopsine)等电点(isoelectric point ,PI)迪克曼反应(Dieckmann reaction )狄尔斯-阿尔德(Diels-Alher)电场扫描(electric field scan)电性效应(electromeric effect)电荷转移络合物(charge-transfer complex)碘仿试验(iodoform test)碘值( iodine number )淀粉(starch)敌敌畏(dichlorovos)蝶啶(pteridine)丁烯二酸(butene dioic acid)定位规则(orientationg rule)动力学概念(dynamical concept)豆甾烷(stigmastane)毒芹碱(coniine)毒扁豆碱(physostigmine)杜鹃酮 (germacrone)端基效应(end-group effect)对映异构(enantiomerism)对映体(enantiomers)对氨基苯磺酰胺(sulfanilamide)多环芳烃(polycyclic aromatic hydrocarbon)多糖(polysaccharide)多肽(polypeptide)多磷酸酯(polyphosphate ester)E(entgegen,德文,相反之意)EAN规则(EAN rule)莪术醇(curcumenol)鹅去氧胆酸(chemocholic acid)噁唑(oxazole)蒽(anthracene)蒽酚(anthrol)蒽醌(anthraquinones)蒽酮(anthrone)9-蒽酮大黄酚(chrysophanol 9-anthrone)儿茶素(catechin)二烯烃(diene)二氯卡宾(dichlorocarbene)二甲亚砜(dimethyl sulfoxide)二巯基丙醇(dimercaptopropanol )二级结构(secondary structure)二氢黄酮(flavanone)二氢黄酮醇(flavanonol)二氢异黄酮(isoflavanone)二氢查尔酮(dihydrochalcone)二萜类(diterpenoids)番泻苷A、B、C、D(sennoside A、B、C、D) 番茄红素(lycopene)反芳香性化合物(antiaromatic compound)反应历程(reaction mechanism)反应热(heat of reaction)芳香烃(aromatic hydrocarbon)芳香性(aromaticity)芳香性化合物(aromatic compound)芳构化(aromatization)放氮反应(denitrification)飞燕草素(delphinidin)非芳香性化合物(nonaromatic compound)非离子表面活性剂(nonionic)非对映体(diasteroisomer)非质子性溶剂(nonprotonic solvent )非苯芳烃(nonbenzenoid hydrocarbon)菲(phenanthrene)斐林溶液( Fehting solution )费歇尔(E.Fischer)费歇尔投影式(Fischer projection formula)分子轨道(molecular orbital)分子轨道对称性守恒理论(conservation of orbital symmetry theory)分子轨道理论(molecular orbital theory)酚苄明(Phenoxybenzamine)芬克尔斯坦(Finkelstein)芬氟拉明(fenfluramine)粪甾烷(coprostane)氟芬那酸(flufenamic Acid)福井谦一(K.Fukui)傅-克反应(Friedel-Crafts alkylation reaction)傅瑞斯重排(K.fries rearrangement)傅瑞德-克拉天茨反应(Friedel-Crafts reaction)辅酶Q10(coenzyme Q10)呋喃(furan)盖布瑞尔合成法(Gabreil reaction)盖特曼-科希(Gattermann-Koch)反应甘露糖(mannose)甘氨酸(glycine)甘油(glycerol)甘氨胆酸(glycocholic acid)甘草酸(glycyrrhizic acid)甘草次酸(glycyrrhetinic acid) 甘草苷(liquiritin)高丽槐素(maackiain)睾丸素(testosterone)隔离二烯烃(isolated diene)格林那试剂(Grignard reagent)哥美林(Gmelin)共振能(resonance energy)共振论(resonance theory)共振杂化体(resonance hybrid)共振结构式(resonating structure)共轭效应(conjugative effect)共轭体系(conjugation system)共轭二烯烃(conjugated diene)构象(conformation)构象异构(conformational isomerism)构造异构(constitutional isomerism)构型保持(configuration conservation)构型转化(configuration inversion)钩藤碱(rhynchophylline)β—谷甾醇(β—sitosterol)谷氨酸(glutamic acid)谷酰胺(glutamine)古柏尔(A. Couper)古柯碱(cocaine)胍(guanidine )寡糖(oligasaccharide)冠醚(crown ether)光学异构体(optical isomer)硅烷(silane)硅油(silicon oil)过氧化物(peroxide)过氧化物效应(peroxide effect)过渡态(transition state)果糖(fructose)哈沃斯(Haworth)海藻糖(fucose)核磁共振谱(nuclear magnetic resonance spectroscopy)核苷酸(nucleotide)核苷(nucleoside)核酸(nucleic acid)核糖(ribose)(-)-黑金合欢素[(-)melacacidin)]红古豆碱(cuskohygrine)红花苷(carthamin)红外光谱(infrared spectroscopy)互变异构现象(tautomerism)互变异构体(tautomer)胡萝卜素(carotene)胡椒碱(piperine)槲皮素(quercetin)化学键(chemical bond)花色素(anthocyanidin)环烃(cyclic hydrocarbon)环氧化反应(epoxidation)环加成反应(cycloaddition recation)环状碳架(cyclic carbon constitution)环己二酮(cyclic hexanedione)环糊精(cyclodextrin)α,β-环氧酸酯(α,β-cycloxacid ester)黄柏素-7-O-葡萄糖苷(phellamurin)黄芩素(baicalein)黄芩苷(baicalin)黄杉素(taxifolin)黄酮(flavonoid)黄酮醇(flavonol)黄烷醇(flavanol)黄体酮(progesterone)磺胺(sulfanilamide)磺化反应(sulfonation)活化能(energy of activation)霍夫曼(R.Hofmann)霍夫曼降解反应(Hoffmann degradation)霍夫曼消除(Hoffmann elimination)霍夫曼彻底甲基化反应(Hoffmann exhaustive methylation)几何异构体(geometricalisomer)己二胺(hexanediamine)季铵盐(quaternary ammonium salt)季铵碱(quaternnary ammonium hydrate )季膦盐( quaternary phosphonium salt )激素(hormone)甲孕酮(methporgestin)甲基睾丸素(methyl testosterone)甲基锂(lithium methlde)甲壳质(chitin)价键学说(valence bond method)假酸式(pseudo-acid form )σ键(σbond)σ键迁移反应(sigmatropic reaction)π键(πbond)碱基配对规律(base pairing rule)姜烯(zingiberene)胶束(micelle)交叉醇醛缩合反应(crossed aldol reaction)金合欢醇(farnesol)金属有机化合物(metalloorganic compound)金雀花碱(sparteine)金鸡宁(cinchonine)金刚烷胺(symmetrel)紧密离子对(tightness ionpair )精氨酸(arginine)竞争反应(competing reaction )聚合物(polymer)聚合反应(polyreaction)聚集二烯烃(cumulative diene)锯架式(andiron formula ; sawhorse projection formula) 卡宾(碳烯)(Carbene)开息纳尔-武尔夫(Kishner-Wolff)-黄鸣龙法凯库勒(A. Kekule)康尼查罗(Cannizzaro ) 反应科尔贝(H. Kolbe)科瑞—郝思反应(E.J.Cory—H.House reaction)可的松(cortisone)可见-紫外光谱(visible-ultraviolet spectroscopy)克莱森-斯密特(Claisen-Schmidt)反应克脑文盖尔(Knoevenagel)反应克莱门森(Clemmensen)还原反应克莱森重排(Claisen rearrangement)克莱森缩合反应(Claisen condensation reaction ) 柯尔柏-施密特反应(Kolbe-schmidt reaction)柯亚素(chrysarobin)壳糖胺(chitosamine)苦参碱(matrine)库切洛夫反应(Kutchcrov reaction)奎宁(quinine)喹啉(quinoline)醌(quinones)醌氢醌(quinhydrone)莱普西汀(leptosidin)赖氨酸(lysine)兰尼镍(Raney Ni)莨菪碱(hyoscyamine)雷公藤甲素(triptolide)利血平(reserpine)立体选择性(stereoselective)立体专一性(stereospecific)立体异构(stereoisomer)离域(delocalization)离域能(delocalization energy ;delocalized energy)离域电子(delocalized electron)离去基团(leaving group )链引发阶段(chain initiation step)链增长阶段(chain propagation step)链终止阶段(chain termination step)链状碳架(chain carbon constitution)亮氨酸(leucine)林德拉(Lindlar)膦叶立德(phosphorus ylide)膦(phosphureted hydrogen)鏻盐(phosphorate)膦酸(phosphonic acid )硫脲(thiourea )硫醇(thioalcohol )硫醚(thioether )硫酚(phenylsulfhydryl )留氮反应(reaction of nitrogen retention) 龙脑(borneol)卤代反应(halogenation)卤仿(haloform)卤仿反应(haloform reaction )卢卡斯试剂(Lucas reagent)芦荟大黄素(aloe-emodin)芦丁(rutin)α-卵磷脂(α-lecithine )轮烯(annulene)酪氨酸(tyrosine)罗勒烯(ocimene)罗森孟德(Rosenmund)还原法螺环烃(spiro hydrocarbon)氯乙酸甲酯(methyl chloroacetate) (chloro acetyl formate) 绿茶多酚(green tea polyphenols)马尔可夫尼可夫(Markovnikov)规则麻黄碱(ephedrine)吗啡(morphine)麦可拉费蒂(Mclafferty)麦芽糖(maltose)麦角甾醇(ergostenol)麦角新碱(ergometrine)麦克尔加成(Michael addition)满尼希(Mannich)反应梅尔外英-彭多夫(Meerwein-Poundorf)还原反应酶(enzyme)没食子儿茶素(gallocatechin)没食子儿茶素没食子酸酯(gallocatechin gallate)脒基(amidino)嘧啶(pyrimidine)咪唑(imidazole)那可汀(narcotine)钠汞齐反应(natrium amalgam reaction)萘(naphthalene)脑磷脂(cephalin)内消旋体(meso-form)尼科尔棱镜(Nicol prism)脲(尿素) (urea)鸟嘌呤(guanine)尿嘧啶(uracil)柠檬醛(citral)苧烯(limonene)牛磺胆酸(taurocholic acid)纽曼投影式(Newmans projection formular)扭转能(torsional energy)扭转张力(torsional strain)欧芬脑尔氧化反应(Oppenaner oxidizing reaction)偶氮基(azo)偶合(偶联)反应(coupling reaction)偶合组分(或偶合剂)(coupling agent )偶极-离子键(dipolar-ionic bond )蒎烯(pinene)硼氢化反应(hydroboration))硼氢化钠(NaBH4吡哆醛(pyridoxal)吡咯(pyrrole)吡喃(pyran)吡嗪(pyrazine)吡唑(pyrazole)吡啶(pyridine)嘌呤(purine)频哪醇(pinacol)平面偏振光(plane polarized light)平伏键(e键,equatorial bonds)苹果多酚(apple polyphenols)普鲁卡因(procaine )葡萄糖(glucose)歧化反应(disproportionation reaction )前列腺素( prostaglandin)前线轨道(frontier orbital)理论茜草素(alizarin)茜素型(alizarin-type)强心苷(cardiac glycosides)羟肟酸(hydroximic acid )β-羟基醛(β-hydroxy aldehyde )桥环烃(bridged hydrocarbon)鞘磷脂(sphingomyelinicacid)亲电性试剂(electrophile)亲电加成反应(electrophilic addition)亲电取代(electrophilic substitution)亲核试剂(nucleophilic reagent)亲核加成反应(nucleophilic addition)亲核取代(nucleophilic substitution)亲核取代反应历程(nucleophilic substitution reavtion mechanism) 亲双烯体(dienophile)芹菜素(apigenin)氢解( hydrogenolysis)氢化苯基锡(hydrogenation benztin)氢化正丁基锡( hydrogenation butyltin )氢化油(hydrogenated oil )氢化可的松(hydrocortisone)氢化热(heat of hydrogenation)氢甲酰化法(hydroformylation)氢键(hydrogen bond)清风藤碱(sinoacutine)琼斯试剂(Jones reagent)炔烃(alkyne)热力学概念(thermodynamic conception )溶剂化效应(solvating effect)乳糖(lactose)瑞穆尔-蒂曼反应(Reamer-Timann reaction)萨哈斯投影式(Sawhares projection)噻吩(thiophene)噻唑(thiazole)三萜(triterpenoids)三甲基铝(trimethyl aluminium)三级结构(tertiary structure)三线态(triplet state)三苯基膦(triphenyl phosphine)三磷酸腺苷(adenosine triphosphate)桑得迈尔反应(Sandmeyer reaction)桑得迈尔—盖特曼反应(Sandmeyer-Gattermann reaction)色氨酸(tryptophan)色谱法(chromatography)沙瑞特试剂(Sarrett reagent)鲨烯(squalene)山油柑碱(acronycine)山扁豆双醌(cassiamine)山梗菜碱(lobeline)肾上腺皮质激素(adrenal cortex hormone)生物甲基化(biological methylate)18电子规则(18- electron rule)史蒂文斯重排(Stevens rearrangement)石松碱(lycopodine)士的宁(strychnine)矢车菊素(cyanidin)手性(chirality)水苏碱(stachydrine)双蒽核(bi-anthracene nucleus)双烯体(diene)顺反异构(cistrans isomerism)顺反异构体(cis-trans isomer)四氢巴马汀(tetrahydropalmatine)四级结构(quaternary structure)四氢硼钠反应(sodium borohydride reaction) 四萜(quadruterpene)四甲基硅烷(tetramethylsilane)丝氨酸(serine)松香酸(abietic acid)苏氨酸(threonine)酸败(rancidity )缩醛(acetal)缩二脲反应(biuret reaction)肽(peptide)肽键(peptide bond)碳水化合物(carbohydrate)碳酰氯(carbonyl chloride ;phosgene )糖类(saccharide)糖苷(glycoside)糖原(glycogen)天冬氨酸(aspartic acid)天精(skyrin)天竺葵素(pelargonidin)萜类化合物(terpenoids)同系列(homologous series)同系物(homolog)同分异构体(isomer)酮(ketone)透析法(permeation)1-吐根碱(1-emetine)脱羧反应(decarboxylic reaction)娃儿藤定碱(tylophorinine)瓦尔登转化(Walden inversion)外消旋体(racemic mixture)外消旋化(racemization)烷烃(alkane)维生素A(vitamin A)维生素B12(vitamin B12)维生素K1、K2(vitamin K1、K2)维蒂希反应(Wittig reaction)伪麻黄碱(pseudoephedrine)威尔克森(wilkinson)威廉森合成法(Williamson synthesis)武勒(F. Wohler)无色矢车菊素(leucocyanidin)伍德沃德(R.B.Woodward)武兹反应(A.Wurtz reaction)烯烃(alkene)系统命名法(systematic nomenclature)西佛碱(Schiff ’s base)希夫(schiff)试剂吸电子共轭效应(electronwithdrawing conjugative effect) 喜树碱(camptothecine)西佛碱(schiff base)希曼反应(G.Schiemann reaction)纤维二糖(cellobiose)纤维素(cellulose)腺嘌呤(adenine)硝化反应(nitration)消除反应(elimination reaction)小檗碱(berberine)硝基化合物(nitro compounds)协同反应(concerted reaction)缬氨酸(valine)(±)—新薄荷醇[(±)—neomenthol]兴斯堡反应(Hinsberg reaction)胸腺嘧啶(thymine)12-15休克尔规则(Hückel rule)比旋光度(specific rotatory power)旋光仪(optical rotation instrument)旋光异构体(optical isomer)血红素(haemachrome)亚硝酸(nitrous acid)烟碱(nicotine)延胡索乙素(tetrahydropalmatine)盐酸-镁粉反应(HCl-Mg powder reaction)盐酸-锌粉反应(HCl-Zn powder reaction)盐(oxonium salt)氧化苦参碱(oxymatrine)氧化蒽酚(oxanthranol)氧化态(oxidation state)氧化值(oxidation number)阳离子表面活性剂(cationic surface active agent)叶黄素(phylloxanthin)叶绿素(chlorophyll)一叶萩碱(securinine)一野百合碱(monocrotaline)一级结构(primary structure)乙硼烷(diborane)1-乙炔基环戊醇(1-ethynyl cyclopentanol )乙二胺(ethylene diamine)乙烯酮(ethenone ;ketene )乙酸(acetic acid)乙二酸(ethanedioic acid )异甘草素(isoliquiritigenin)异黄酮(isoflavone)异鼠李素(isorhamnetin)异钩藤碱(isorhynchophylline)异亮氨酸(isoleucine)异头物(anomer)异头效应(anomeric effect)异噁唑(isoxazole)异噻唑(isothiazole)异腈(胩)(isonitrile)异喹啉(isoquinoline)胰岛素(insulin)阴离子表面活性剂(anionic surface active agent)茚三酮(ninhydrin )吲哚(indole)罂粟碱(papaverine)油脂(axunge;grease;lipin;)有效原子序数(effective atomic number)有机金属化合物(organometallic compound)有机锂(organic-Li) (organic lithium ) (organolithium compound) 诱导效应(inductive effect)羽扇豆碱(lupinine)愈创木奥(guaiazulene)原花色素(proanthocyanidin)鸢尾苷(iridin)原子轨道(atomic orbital)Z(Zusammen,德文,在一起之意)杂化轨道(hybrid orbital)杂环碳架(heterocycle carbon constitution)甾体化合物(steroidal compound)皂化反应(saponification reaction)皂化值(saponification value)扎依采夫(Saytzeff)规则樟柳碱(anisodine)樟脑(camphor)蔗糖(sucrose)-折叠(beta-pleated sheet)蒸馏法(distillation)质谱(mass spectroscopy)质子性溶剂(protonic solvent)脂环烃(alicyclic hydrocarbon;cycloalkane)直立键(a键,axial bond)重氮化反应(diazotization reaction)重氮盐(diazonium salt)重氮组分(diazocomponent)重氮甲烷(diazomethane)周环反应(pericyclic reaction)转化糖(invert sugar)自由基(free radical)自由基链反应(free radical chain reaction)β-紫罗兰酮(β-ionone )。

氯霉素一种具有旋光活性酰胺醇类抗生素

氯霉素一种具有旋光活性酰胺醇类抗生素

中文名:氯霉素英文名: Chloramphenicol化学式: C11H12N2O5Cl2IUPAC名: D-苏式-(-)-N-[α-(羟基甲基)-β-羟基-对硝基苯乙基]-2,2-二氯乙酰胺CAS号: 56-75-7外观:白色或微黄色针状或片状晶体、味苦。

在甲醇、乙醇、丙酮或丙二醇中易溶,在水中微溶。

一种具有旋光活性的酰胺醇类抗生素。

熔点: 149-153℃摩尔质量: g/mol溶解度(水): g/L (25° C)酸碱度PH ~比旋度+~+氯化物≤100ppm干燥失重≤%炽灼残渣≤%含量 %~%用途:要紧用于伤寒、副伤寒和其他沙门菌、脆弱拟杆菌感染。

Product Name :ChloramphenicolCharacters :A white to grayish-white or yellow-white, fine crystalline powder or fine crystals , needles or elongatedMelting range:~℃PH :~Chloride :≤100ppmLoss on drying:≤%Sulphated ash :≤%Assay :%~%Specific optical rotation:+~+氯霉素价钱KG 湖北远成药业优质优价邮箱:索样请Q 9 +86- +86-27- 氯霉素是由委内瑞拉链丝菌产生的抗生素。

属抑菌性广谱抗生素。

灵敏菌有肠杆菌科细菌及炭疽杆菌、肺炎球菌、链球菌、李斯特氏菌、葡萄球菌等。

衣原体、钩端螺旋体、立克次体也对本品灵敏。

因对造血系统有严峻不良反映,需慎重利用。

生化作用氯霉素类抗生素可作用于细菌核糖核蛋白体的50S亚基,而阻挠蛋白质的合成,属抑菌性广谱抗生素。

细菌细胞的70S核糖体是合成蛋白质的要紧细胞成份,它包括50S和30S两个亚基。

氯霉素通过可逆地与50S亚基结合,阻断转肽酰酶的作用,干扰带有氨基酸的胺基酰-tRNA终端与50S亚基结合,从而使新肽链的形成受阻,抑制蛋白质合成。

骨源性细胞因子在激素性股骨头坏死发生发展中的研究进展

骨源性细胞因子在激素性股骨头坏死发生发展中的研究进展

-综述•骨源性细胞因子在激素性股骨头坏死发生发展中的研究进展蒋捷,黄林科,胡峰△(广西医科大学第二附属医院,广西南宁530007)[摘要]股骨头坏死是骨外科常见的难治性疾病,其机制仍有待研究。

目前为止,医源性糖皮质激素是非创伤性股骨头坏死的主要原因。

激素的长期使用可导致股骨头骨细胞凋亡、血液循环障碍所致缺血缺氧,最终导致股骨头塌陷。

激素性股骨头坏死的发生发展与骨组织中细胞直接接触和其间接分泌的细胞因子调控相关。

本文综述了骨组织中成骨细胞分泌的核因子k B受体结合配体,骨保护素,骨碱性磷酸酶,骨细胞表达硬化素,破骨细胞分泌骨形态发生蛋白2等因子在SONFH的研究进展,骨源性细胞因子在SONFH中扮演重要作用。

[关键词]骨源性细胞因子;激素性股骨头坏死;临床分型;病理表现;综述[中图分类号]R681[文献标识码]A[文章编号]961-5639(2621)61-482-04doi:16.3969/E R w x961-5639.402000025Resevrch prggress of bone derived cytokines in developmenS of steaid induced osteynecrgsis of the femorai hecdJIANG Jia,HUANG Lia-Ue,HU Feng'(Department of OrtUopebic trauma,the Second Affiliated Hospital of Guanypi Medical Univer­sity?Nanning Citp,Guangpi Zhuang Autonomous Repiox530007,China)J Abstrach]Avascular necrosis of the femoral heah is a common refracton disease in ortUopebic shraeru/whose mechanism remains to be studied.So far,iatngenic glucocorncoids are the main cause of nox-EaumaWe necrosis of the femoral heah.Long term treatment of glucocorncoids leafs to osteocyte apoptosis of femoral heah,ischemia and hypoxia caused bp blood cinulaWon OisorUer,and eventuaLy leafs to coXapse of femoral heah.The occurrence and Oevelopment of steroid induced osteonecrosis of the femoral heah are related to the direct contact of cells in bone tissue and the repulaLox of cypdines secreted indirectly.We reviewed the research progress of Nuclear factor kaypa B receptor binding ligand,RANKL,OsPoproPpeEn;OPG and Bone aldaLne phosphamse;BAP secreted bp osteoblasts, eceeeohnt(SOST)peoducedbsoeheocsheeatdBotemoepeogetehncpeohent-2BMP-2eeceehedbsoeheoceaehenteheeondntducedoeheote-eeoeneoeheeeemoeaeeead0Botedeeneedeshoenteepeasatnmpoehatheoeenteheeondntdueedoeheoteeeoeneoeheeeemoeaeeead0J Key woras]Bone PeEved cytodines;2proid induced necrosis of the femoral heah;Clinical classification;PatUologicai manifestation;Reenew股骨头坏死(OWewecrwis of femoral heah,ONFH)是骨外科常见的难治性疾病,严重影响患者的生活质量。

阿司咪唑

阿司咪唑

合成方法
合成方法
化合物(I)和碘甲烷在乙醇中回流8h,环合得到化合物(Ⅱ)。再水解脱去酯基,得到化合物(Ⅲ)。用对甲氧 基苯乙基溴进行N-烷基化,得化合物(Ⅳ)。再用对氟苄基溴烷基化,得阿司咪唑。
1. 1-[(4-氟苯基)甲基]-苯并咪唑-2-(3H)-酮的制备
在反应瓶中加入2-羟基苯并咪唑5.0g(37.3mmol)和NaH 1.6g(53mmol)(NaH含量大约为80%,浸入矿物油中) 的DMF 100ml的悬浮液.加毕.在60ºC.(最好有N2保护)搅拌反应1h.再加入4-氟苄基氯(FBC)5.4g(37mmol),加热 ( 6 0 ºC ) 搅 拌 反 应 5 . 5 h . 冷 却 至 室 温 后 加 入 冰 水 7 0 0 m l , 用 二 氯 甲 烷 ( 5 0 0 m l × 2 ) 提 取 . 有 机 层 用 食 盐 水 洗 . 无 水 N a 2 S O 4 干燥.过滤.滤液减压浓缩.剩余物用石油醚析晶.得1-[(4-氟苯基)甲基]-苯并咪唑-2-(3H)-酮固体8.0g,为无色 结 晶 m p 1 7 8 ~ 1 7 9 ºC , 收 率 8 8 % .
治疗措施
阿司咪唑中毒的治疗要点为: 1.大量摄入者予洗胃,后灌服活性炭和导泻。 2.对心肌抑制和Q-T间期延长者予5%碳酸氢钠250ml静注可能有效。 3.对症、支持治疗。
专家点评
专家点评
阿司咪阿司咪唑自1983年上市以来,在许多国家得到了广泛应用。国外研究显示阿司咪唑治疗荨麻疹的总有 效率为74%。国内的一项多中心双盲安慰剂对照试验表明阿司咪唑对急性荨麻疹的总有效率为82.9%,对慢性荨麻 疹的总有效率为86.0%,均显著高于安慰剂,主要不良反应为嗜睡、倦怠、口干等,连续用药3个月的患者中,半 数有食欲及体重增加。阿司咪唑的心脏毒性虽然发生率较低,但由于后果严重,已限制了它的应用。阿司咪唑为 强效和长效的H1受体拮抗剂,无中枢镇静和抗毒蕈碱样作用。代谢产物去甲阿司咪唑仍有抗胆胺作用。长期服用 可增进食欲和增加体重,服用过量可引起心脏Q-T间期延长和室性心律失常。适用于各种原因引起过敏性疾病。

氯化镧 氯化亚铈 性质

氯化镧 氯化亚铈 性质

【中文名称】氯化镧【英文名称】lanthanum chloride【结构或分子式】LaCl3 .6O H2【密度】3.842(无水)【熔点(℃)】70(六水),860(无水)【沸点(℃)】>1000(无水)【性状】六水物:微红色或灰色结晶或块状物,无水物:白色粉状结晶。

【溶解情况】六水物:能溶于水;无水物:易溶于汽水中,热水中分解,易溶于乙醇和吡啶,在乙醚和苯中不溶。

【用途】主要用作制备石油裂化的催化剂,也可作提取单一稀土产品或冶炼富集混合稀土金属的原料。

【制备或来源】将氧化镧或氢氧化镧溶于盐酸,在水浴上加热浓缩可得六水氯化镧。

将六水氯化镧在减压33.33千帕的干燥氯化氢气流中,分三步(70℃,160℃,250℃)脱水。

也可由氯化稀土或稀土硫酸铵复盐用氢氧化钠溶解,再经空气氧化、稀盐酸酸浸而得。

【其他】六水物:易潮解,遇碱生成氢氧化物或氯氧化物沉淀。

无水物:强烈吸湿,在空气中加热易分解成氯氧化物。

【毒性】半数致死量(狗,经口)4200mG/kG。

有刺激性含量(La2O3),≥45.0 %水合氯化镧LaCl3·7H2O的热脱水分析研究其在氩气气氛下的热分解脱水反应可以分解成四个,分别在0.0~119.3℃,119.3~165.3℃,165.3~197.4℃,197.4~237.8℃的四个温度段内,每一步的失水数分别为1H2O,3H2O,2H2O及1H2O.氯化亚铈性状:无色块状晶体。

能溶于水、丙酮和酸。

熔点 848 °C(lit.)沸点 1727 °C密度 3.97 g/mL at 25 °C(lit.)闪点 1727°C【中文名称】氯化铈【英文名称】cerium chloride【结构或分子式】CeCl3.6O H2【密度】3.92【熔点(℃)】848【沸点(℃)】1727【性状】无色块状晶体。

【溶解情况】能溶于水、丙酮和酸。

【用途】用作石油催化剂、铈盐原料,也用于制金属铈等。

木糖赖氨酸脱氧胆酸盐琼脂培养基说明书

木糖赖氨酸脱氧胆酸盐琼脂培养基说明书

广东环凯微生物科技有限公司网址: 地址:广州市黄埔区科学城神舟路788号邮编:510663传真:860288778876产品说明书Product Manual【产品名称】通用名称:木糖赖氨酸脱氧胆酸盐琼脂培养基英文名称:Xylose Lysine Desoxycholate Agar 【产品编号与包装规格】产品编号产品类型包装规格029997干粉250g/瓶【产品用途】用于药品中沙门氏菌的选择分离培养。

【检验原理】酵母浸出粉提供氮源、维生素、生长因子;氯化钠维持均衡的渗透压;木塘、乳糖、蔗糖为可发酵糖类,产酸使酚红指示剂变黄;去氧胆酸钠抑制革兰氏阳性菌,但不影响沙门氏菌的生长;硫代硫酸钠可被某些细菌还原硫化氢,与柠檬酸铁铵中的铁盐生成黑色硫化铁;琼脂是培养基的凝固剂;酚红为pH 指示剂。

称取本品55.2g,加入蒸馏水或去离子水1L,搅拌加热煮沸至完全溶解,冷却至50℃制备平板备用。

【质量控制】贮存于避光、干燥处,用后立即旋紧瓶盖;贮存期三年。

【注意事项】1、称量时注意粉尘,佩戴口罩操作以避免引起呼吸道系统不适。

2、干粉培养基使用后立即旋紧瓶盖,避免吸潮结块。

贮存于避光、干燥处。

广东环凯微生物科技有限公司网址: 地址:广州市黄埔区科学城神舟路788号邮编:510663传真:************-8619************8602************887788763、质检报告可以登录环凯网站 ,打开“质检报告”页面,输入产品批号下载。

【废物处理】检测之后带菌物品置于121℃下高压灭菌30分钟后处理。

【执行标准】Q/HKSJ 03广东环凯微生物科技有限公司企业标准普通微生物培养基【说明版本】2020年01月24日【参考文献】《中华人民共和国药典》2020年版。

常压无氯盐溶液制备α-CaSO·40.5H2O晶体研究 

常压无氯盐溶液制备α-CaSO·40.5H2O晶体研究 

第53卷第5期2024年5月人㊀工㊀晶㊀体㊀学㊀报JOURNAL OF SYNTHETIC CRYSTALS Vol.53㊀No.5May,2024常压无氯盐溶液制备α-CaSO 4·0.5H 2O 晶体研究李雪礼,郭静静,霍腾飞,白佳乐,张琰图(延安大学化学与化工学院,陕西省化学反应工程重点实验室,延安㊀716000)摘要:本文以Na 2SO 4溶液为反应介质,研究了反应温度㊁反应时间㊁液固比㊁pH 值㊁Na 2SO 4质量分数对α-CaSO 4㊃0.5H 2O 生成的影响㊂结果表明,在Na 2SO 4质量分数为12.5%,液固比为5ʒ1,pH 值为7,反应温度为97ħ,反应时间为4h 的条件下,制备出平均长度46.0μm㊁平均长径比17.23㊁形貌均一的α-CaSO 4㊃0.5H 2O 晶体㊂常压无氯盐溶液方法克服了氯离子腐蚀工业设备㊁污染环境等缺点,为高值化利用磷石膏提供重要的技术支持㊂关键词:常压;无氯盐;硫酸钠;α-半水硫酸钙;形貌均一;高值化利用中图分类号:O784㊀㊀文献标志码:A ㊀㊀文章编号:1000-985X (2024)05-0855-09Preparation of α-CaSO 4㊃0.5H 2O Crystals from Chlorine-Free Salt Solution at Atmospheric PressureLI Xueli ,GUO Jingjing ,HUO Tengfei ,BAI Jiale ,ZHANG Yantu(Shaanxi Key Laboratory of Chemical Reaction Engineering,College of Chemistry and Chemical Engineering,Yan an University,Yan an 716000,China)Abstract :The effects of reaction temperature,reaction time,liquid-solid ratio,pH value and Na 2SO 4mass fraction on the generation of α-CaSO 4㊃0.5H 2O were investigated using Na 2SO 4solution as the reaction medium.The results show that α-CaSO 4㊃0.5H 2O crystals with an average length of 46.0μm,an average aspect ratio of 17.23and a homogeneous morphology are prepared under the conditions of Na 2SO 4mass fraction of 12.5%,liquid-solid ratio of 5ʒ1,pH value of 7,reaction temperature of 97ħand reaction time of 4h.The method of chloride-free salt solution under atmospheric pressure overcomes the drawbacks of chloride ion corrosion of industrial equipment and environmental pollution,providing important technical support for the high value utilization of phosphogypsum.Key words :atmospheric pressure;chlorine-free salt;sodium sulfate;α-calcium sulfate hemihydrate;homogeneous morphology;high value utilization ㊀㊀收稿日期:2023-12-26㊀㊀基金项目:国家重点研发计划(2019YFC1905800);陕西省自然科学基础研究计划(2023-JC-YB-117);延安大学科研专项(2023JBZR-015),陕西省大学生创新创业训练计划(S202310719098)㊀㊀作者简介:李雪礼(1980 ),男,河南省人,博士,副教授㊂E-mail:lzlixueli@ 0㊀引㊀㊀言α-CaSO 4㊃0.5H 2O 晶体具备高凝胶强度,是重要的胶凝矿物[1],被广泛应用于建材㊁医疗㊁装饰㊁生物等领域[2-5]㊂制备α-CaSO 4㊃0.5H 2O 的原材料一般为不可再生的天然石膏,成分是CaSO 4㊃2H 2O㊂在长江两岸的化工园区中,大量的工业副产物磷石膏堆积,易引起土地和水资源的污染㊂磷石膏的主要成分为CaSO 4㊃2H 2O,将磷石膏作为原料制备α-CaSO 4㊃0.5H 2O 晶体既保护天然石膏,又解决磷石膏堆积造成的环境问题,实现变废为宝㊂目前将CaSO 4㊃2H 2O 晶体向α-CaSO 4㊃0.5H 2O 晶体转化的常用方法有常压盐溶液法[6]和水热法[7]㊂常压盐溶液法制备α-CaSO 4㊃0.5H 2O 晶体是指在常压下,通过将液固比(溶液体积数与固体质量数比值)一定的盐溶液和CaSO 4㊃2H 2O 进行反应,制备α-CaSO 4㊃0.5H 2O 晶体的方法[8]㊂此方法的反应温度比水热法更低,反应过程可控,是前景较好的制备α-CaSO 4㊃0.5H 2O 晶体的方法㊂徐伟856㊀研究论文人工晶体学报㊀㊀㊀㊀㊀㊀第53卷等[9]以稀土石膏为原料,利用常压盐溶液法制备出平均长度为61μm,长径比达30.5的硫酸钙晶体㊂Zhang 等[10]采用高重力反应沉淀法结合常压盐溶液法制备出长1~6μm,宽1~2μm 的低长径比棱柱形α-CaSO 4㊃0.5H 2O 晶体㊂谢晴等[11]以磷石膏为原料在酸性条件下制备无水CaSO 4晶体,采用一步法制备出长径比为3~8的无水CaSO 4晶体㊂工业上用常压溶液法制备α-CaSO 4㊃0.5H 2O 晶体一般采用的盐溶液为氯盐体系溶液,对生产装置的腐蚀性极大,排出的含氯废水如何解决也是较为棘手的问题㊂基于此,本试验旨在通过常压无氯盐溶液法,以磷石膏为原料,以无氯盐溶液Na 2SO 4为反应介质,研究制备硫酸钙晶体的工艺参数,考察溶液pH 值㊁Na 2SO 4质量分数㊁液固比㊁温度对将CaSO 4㊃2H 2O 转化为α-CaSO 4㊃0.5H 2O 晶体的影响,为常压无氯盐溶液法高值化利用磷石膏提供技术支持㊂1㊀实㊀㊀验1.1㊀实验原料和制备方法硫酸钙(CaSO 4㊃2H 2O,A.R.,麦克林化学试剂)㊁盐酸(HCl,A.R.)㊁氢氧化钠(NaOH,A.R.)均为国药集团化学试剂,硫酸钠(Na 2SO 4,A.R)㊁硝酸钠(NaNO 3,A.R.)㊁硫酸镁(MgSO 4,A.R.)均为天津科密欧试剂,实验中所用的水均为去离子水㊂首先将50mL 一定质量分数的Na 2SO 4水溶液加入装有球形冷凝器的规格为250mL 的三颈烧瓶中,再将10g CaSO 4㊃2H 2O 加入三颈烧瓶中,搅拌速率为100r /min,设置温度为97ħ㊁在恒定的温度下反应4h㊂待反应结束后,将溶液进行真空抽滤,将分离出的产物分别用蒸馏水和无水乙醇进行洗涤㊂之后放入烘箱在45ħ条件下干燥6h㊂1.2㊀性能测试与表征采用上海缔伦光学仪器有限公司TL3701偏光显微镜观察晶须形貌并统计晶须长度㊁直径㊁长径比㊂采用岛津公司XRD-7000型X 射线衍射仪(XRD)对样品的相态组成进行分析㊂采用菲达康公司Q50型扫描电子显微镜(SEM)观察样品的微观形貌,利用附带能谱仪对样品进行定点化学元素含量分析㊂2㊀结果与讨论2.1㊀反应温度对制备α-CaSO 4·0.5H 2O 的影响为探究反应温度对制备α-CaSO 4㊃0.5H 2O 的影响,设置Na 2SO 4质量分数为12.5%,转速为100r /min,pH 值为7,液固比为5ʒ1,反应时间为4h㊂图1为不同反应温度条件下制备得出的产物的XRD 图谱㊂从图1中可以看出在反应温度为87ħ时,产物的谱图中未出现CaSO 4㊃0.5H 2O 的特征衍射峰,说明产物不是α-CaSO 4㊃0.5H 2O 晶体;在反应温度为92ħ时,谱图中开始出现CaSO 4㊃0.5H 2O 的特征衍射峰;反应温度为97㊁102ħ时,产物的衍射峰与CaSO 4㊃0.5H 2O 的特征衍射峰一一对应,生成的产物为α-CaSO 4㊃0.5H 2O 晶体㊂图1㊀不同反应温度下制备的产物XRD 图谱Fig.1㊀XRD patterns of products prepared at different reaction temperatures图2为不同温度下制备的α-CaSO 4㊃0.5H 2O 晶体显微形貌图,从图中得知,温度对产物形貌的影响较大,在反应温度为87ħ时,产物未完全转化为α-CaSO 4㊃0.5H 2O 晶体,产物的形貌为不规则的晶体;在反应温度为92ħ时,产物的形貌大部分为针状,且存在少量不规则状晶体,结合图1产物的XRD 图谱,可以看出产物为CaSO 4㊃2H 2O 和α-CaSO 4㊃0.5H 2O 晶体混合物;在反应温度为97ħ时,产物为α-CaSO 4㊃0.5H 2O 晶体;在反应温度为102ħ时,产物的形貌与97ħ相比未发生明显的变化,结合XRD 图谱,证明随着温度的升高,晶体的形貌和物相并未发生明显变化㊂图3为不同温度条件下制备的α-CaSO 4㊃0.5H 2O 晶体的平均长度和宽度及长径比图㊂由图1和图2可知,在㊀第5期李雪礼等:常压无氯盐溶液制备α-CaSO 4㊃0.5H 2O 晶体研究857㊀反应温度大于92ħ时,产物为α-CaSO 4㊃0.5H 2O 晶体㊂反应温度分别为92㊁97㊁102ħ时,α-CaSO 4㊃0.5H 2O 晶体的平均长度分别为36.7㊁42.7㊁42.5μm,平均宽度分别为2.2㊁2.3㊁2.3μm,平均长径比分别为16.7㊁17.0㊁16.5㊂选择97ħ作为制备α-CaSO 4㊃0.5H 2O 的最佳温度㊂图2㊀不同反应温度下制备产物的显微形貌图(10倍)Fig.2㊀Microscope pictures of the products prepared at different reaction temperatures(10ˑ)2.2㊀反应时间对制备α-CaSO 4·0.5H 2O 晶体的影响图4为不同反应时间下产物的XRD 图谱㊂从图中得出反应时间2~8h 所生成的产物的衍射峰与CaSO 4㊃0.5H 2O 的特征衍射峰相吻合,分别对应CaSO 4㊃0.5H 2O 的(200)㊁(020)㊁(400)和(204)晶面[12],表明生成的产物均为α-CaSO 4㊃0.5H 2O 晶体㊂图5为不同反应时间下产物的显微形貌图㊂可以看出,反应时间为2㊁4㊁6㊁8h,生成的产物均为针状晶体,在反应时间为4h 时,制备的晶体较为完整均一㊂图3㊀不同反应温度下制备α-CaSO 4㊃0.5H 2O晶体的平均长度㊁宽度和长径比Fig.3㊀Average length,width and aspect ratio of α-CaSO 4㊃0.5H 2O crystals prepared at different reactiontemperatures 图4㊀不同反应时间下制备的晶体的XRD 图谱Fig.4㊀XRD patterns of the crystals prepared for different reaction time858㊀研究论文人工晶体学报㊀㊀㊀㊀㊀㊀第53卷图6为α-CaSO 4㊃0.5H 2O 晶体的平均长度㊁平均宽度及平均长径比图㊂在反应时间分别为2㊁4㊁6㊁8h时,针状的α-CaSO 4㊃0.5H 2O 晶体的平均长度分别为35.0㊁43.6㊁35.6㊁38.3μm,平均宽度为2.4㊁2.5㊁2.3㊁3.2μm,对应的平均长径比分别为16.1㊁17.9㊁16.7㊁13.7㊂在反应时间为4h 时,α-CaSO 4㊃0.5H 2O 晶体的长径比最长,而且为使反应进行更完全,本文选择4h 作为反应时间㊂图5㊀不同反应时间下制备的晶体的显微形貌图(10倍)Fig.5㊀Microscope pictures of the crystals prepared for different reaction time(10ˑ)2.3㊀反应溶液pH 对制备α-CaSO 4·0.5H 2O 晶体的影响图7为不同pH 值下产物的XRD 图谱㊂可以看出在溶液的pH 值为3㊁5㊁7㊁8时,产物在14.74㊁25.64㊁29.74㊁31.73ʎ的XRD 衍射峰都与α-CaSO 4㊃0.5H 2O 晶体特征衍射峰基本一致,且与α-CaSO 4㊃0.5H 2O 晶体的(200)㊁(020)㊁(400)和(204)晶面对应,说明在pH 值为3㊁5㊁7㊁8时,生成的产物均为α-CaSO 4㊃0.5H 2O晶体,并未生成其他物质㊂图6㊀不同反应时间下制备α-CaSO 4㊃0.5H 2O晶体的平均长度㊁宽度和长径比Fig.6㊀Average length,width and aspect ratio of α-CaSO 4㊃0.5H 2O crystals prepared for different reactiontime 图7㊀不同溶液pH 值制备的晶体XRD 图谱Fig.7㊀XRD patterns of crystals prepared with different solution pH㊀第5期李雪礼等:常压无氯盐溶液制备α-CaSO 4㊃0.5H 2O 晶体研究859㊀㊀㊀图8为生成产物的显微形貌图,从图中可以看出,pH 值在3㊁5㊁7时的产物均为完整均匀的α-CaSO 4㊃0.5H 2O 晶体㊂图8(d)为pH 值为8时的产物显微镜图,产物虽是α-CaSO 4㊃0.5H 2O 晶体,但形貌大小均匀,小尺寸细碎的晶体较多㊂图8㊀不同溶液pH 值制备的晶体显微镜图(10倍)Fig.8㊀Microscope pictures of crystals prepared with different solution pH(10ˑ)图9为在不同pH 下α-CaSO 4㊃0.5H 2O 晶体的平均长度㊁平均宽度和平均长径比㊂在溶液的pH 值分别为3㊁5㊁7㊁8时,其α-CaSO 4㊃0.5H 2O 晶体的平均长度分别为40.15㊁38.31㊁44.12㊁27.64μm,平均宽度分别为3.17㊁3.06㊁2.45㊁3.11μm,其长径比分别为12.4㊁12.7㊁16.54㊁9.36㊂在不加HCl 和NaOH 调节pH 值时,悬浮液本身的pH 值为7,且在pH 值为7时,产物的平均长径比达到最大,结合产物的XRD 图谱㊁显微形貌图,选择pH 值为7作为本实验的盐溶液最佳pH 值㊂2.4㊀液固比对制备α-CaSO 4·0.5H 2O 的影响图10是不同液固比下产物的XRD 图谱,在液固比为4ʒ1㊁5ʒ1㊁6ʒ1㊁7ʒ1时,所制备的产物在14.78ʎ㊁25.70ʎ㊁29.72ʎ㊁31.84ʎ的衍射峰与α-CaSO 4㊃0.5H 2O 的标准谱的特征衍射峰相对应,分别对应α-CaSO 4㊃0.5H 2O 晶体的(200)㊁(020)㊁(400)㊁(204)晶面㊂证明产物均为α-CaSO 4㊃0.5H 2O 晶体,并未生成其他物质㊂图9㊀不同溶液pH 值下α-CaSO 4㊃0.5H 2O 晶体的平均长度㊁宽度和长径比Fig.9㊀Average length,width and aspect ratio of α-CaSO 4㊃0.5H 2O crystals with different solution pH 图10㊀不同液固比下制备的晶体XRD 图谱Fig.10㊀XRD patterns of crystals prepared with different liquid-solid ratios860㊀研究论文人工晶体学报㊀㊀㊀㊀㊀㊀第53卷图11为不同液固比下产物的显微镜图片,图片中所展现的均为α-CaSO 4㊃0.5H 2O 晶体,图11(a)是液固比为4ʒ1时制备的α-CaSO 4㊃0.5H 2O 晶体,由于添加的固相比例较高,搅拌不均匀,出现相对较多的细碎的晶体㊂图11(b)为液固比5ʒ1时制备的晶体显微镜图,晶体的形貌较为完整均一㊂图11㊀不同液固比下制备出晶体的显微形貌图(40倍)Fig.11㊀Microscope pictures of crystals prepared with different liquid-solid ratios (40ˑ)图12为不同液固比下制备的α-CaSO 4㊃0.5H 2O 的晶体的平均长度㊁平均宽度和平均长径比㊂在液固比为4ʒ1㊁5ʒ1㊁6ʒ1㊁7ʒ1时,α-CaSO 4㊃0.5H 2O 晶体的平均长度分别为41.07㊁46.06㊁42.06㊁41.73μm,平均宽度分别为2.99㊁2.92㊁3.00㊁3.13μm,平均长径比分别为15.98㊁16.54㊁16.42㊁14.67㊂在实验中,经多次验证,液固比为4ʒ1时,悬浮液变得比较黏稠,难以搅拌均匀,考虑到生产效率,选择液固比5ʒ1作为最佳液固比㊂2.5㊀Na 2SO 4的质量分数对制备α-CaSO 4·0.5H 2O 的影响图13为质量分数为0㊁5.0%㊁12.5%㊁15.0%㊁20%的Na 2SO 4盐溶液下制备的产物的XRD 图谱㊂从XRD 谱图中可以看出,在Na 2SO 4的质量分数为0和5.0%时,从产物的衍射峰得出,制备的晶体仍为CaSO 4㊃2H 2O㊂当质量分数大于等于12.5%时,产物的XRD 的衍射峰的位置在14.78ʎ㊁25.68ʎ㊁29.70ʎ㊁31.86ʎ,分别对应α-CaSO 4㊃0.5H 2O 晶体的(200)㊁(020)㊁(400)和(204)晶面,表明所制备的产物为α-CaSO 4㊃0.5H 2O 晶体㊂图12㊀不同液固比下制备的α-CaSO 4㊃0.5H 2O晶体的平均长度㊁宽度和长径比Fig.12㊀Average length,width and aspect ratio of α-CaSO 4㊃0.5H 2O crystals prepared with different liquid-solid ratios图13㊀不同质量分数的Na 2SO 4溶液制备的晶体XRD 图谱Fig.13㊀XRD patterns of crystals prepared from different mass fractions of Na 2SO 4solutions㊀第5期李雪礼等:常压无氯盐溶液制备α-CaSO4㊃0.5H2O晶体研究861㊀图14为添加不同质量分数Na2SO4的产物的显微形貌图㊂图14(a)~(b)为在Na2SO4质量分数为0㊁5.0%下制备的产物,结合图13可以看出CaSO4㊃2H2O并未转化成α-CaSO4㊃0.5H2O晶体,产物仍为CaSO4㊃2H2O㊂图14(c)~(d)为Na2SO4质量分数为12.5%㊁15.0%下制备的产物,其形貌完整均匀㊂图14 (e)显示的是Na2SO4质量分数为20%时制备的α-CaSO4㊃0.5H2O晶体显微形貌图,晶体的形貌较为细小,为晶体状㊂图14㊀不同质量分数的Na2SO4溶液制备出晶体的显微形貌镜(40倍)Fig.14㊀Microscope pictures of crystals prepared from different mass fractions of Na2SO4solutions(40ˑ)图15为不同Na2SO4质量分数下α-CaSO4㊃0.5H2O晶体的平均长度㊁平均宽度和平均长径比㊂由XRD 图谱可知在Na2SO4的质量分数为12.5%㊁15.0%㊁20.0%时,产物为α-CaSO4㊃0.5H2O晶体,晶体的平均长度分别为46.0㊁42.3㊁26.39μm,平均宽度为2.41㊁2.33㊁2.01μm,其对应的平均长径比分别为17.23㊁16.70㊁13.39㊂综上所述,选择Na2SO4的质量分数为12.5%更为合适㊂图15㊀不同质量分数Na2SO4溶液制备的α-CaSO4㊃0.5H2O晶体的平均长度㊁宽度和长径比Fig.15㊀Average length,width and aspect ratio ofα-CaSO4㊃0.5H2O crystals prepared from different mass fraction of Na2SO4solutions 为探究Na2SO4作为盐溶液制备α-CaSO4㊃0.5H2O晶体时,是Na+还是SO2-4起转化作用,分别选择质量分数为12.5%的NaNO3㊁MgSO4溶液在相同的实验条件下,代替Na2SO4溶液制备α-CaSO4㊃0.5H2O晶体㊂图16是制备产物的XRD图谱和显微形貌图㊂由图可知,在相同的反应条件下,MgSO4可以使CaSO4㊃2H2O 转化为α-CaSO4㊃0.5H2O;以NaNO3作为盐溶液制备的产物仍为CaSO4㊃2H2O,并未有α-CaSO4㊃0.5H2O晶体生成㊂表明SO-4在CaSO4㊃2H2O转化为α-CaSO4㊃0.5H2O过程中发挥了重要作用,Na+并未有此作用㊂862㊀研究论文人工晶体学报㊀㊀㊀㊀㊀㊀第53卷图16㊀NaNO3㊁MgSO4溶液制备的晶体XRD图谱和显微形貌图Fig.16㊀XRD patterns and microscope pictures of crystals prepared from NaNO3and MgSO4solutions3㊀结㊀㊀论1)在以Na2SO4为反应介质的无氯盐溶液中,CaSO4㊃2H2O常压下转化为α-CaSO4㊃0.5H2O,制备工艺流程成熟简单,生产过程中避免了氯离子对设备的腐蚀,降低了生产能耗,保护了环境㊂2)反应温度为97ħ,反应时间为4h,液固比为5ʒ1,pH值为7,Na2SO4质量分数为12.5%的条件下,制备出形貌均一的硫酸钙晶须,其平均长度46.0μm,平均长径比为17.23㊂最佳的反应溶液pH值为7,不需要使用酸碱来调节反应的pH,进一步简化了反应工艺,为常压无氯盐溶液法高值化利用磷石膏提供了新思路㊂参考文献[1]㊀牛小超,吴锦绣,柳召刚,等.硫酸钙晶须的研究进展[J].应用化工,2022,51(4):1174-1180+1201.NIU X C,WU J X,LIU Z G,et al.Research progress of calcium sulfate whiskers[J].Applied Chemical Industry,2022,51(4):1174-1180+ 1201(in Chinese).[2]㊀PFÖRRINGER D,HARRASSER N,MÜHLHOFER H,et al.Osteoinduction and-conduction through absorbable bone substitute materials basedon calcium sulfate:in vivo biological behavior in a rabbit model[J].Journal of Materials Science:Materials in Medicine,2018,29(2):17.[3]㊀FAN T T,WANG X S,GAO Y,et al.Investigating the interaction mechanism and effect of different calcium sulfate whiskers on performance ofasphalt binder[J].Construction and Building Materials,2019,224:515-533.[4]㊀HSU H J,WARIS R A,RUSLIN M,et al.An innovativeα-calcium sulfate hemihydrate bioceramic as a potential bone graft substitute[J].Journal of the American Ceramic Society,2018,101(1):419-427.[5]㊀CHEN Q S,ZHU C L,HUO D,et al.Continuous processing of phase-change materials into uniform nanoparticles for near-infrared-triggered drugrelease[J].Nanoscale,2018,10(47):22312-22318.[6]㊀牛小超,吴锦绣,柳召刚,等.硫酸钙晶须的研究进展[J].应用化工,2022,51(4):1174-1180+1201.NIU X C,WU J X,LIU Z G,et al.Research progress of calcium sulfate whiskers[J].Applied Chemical Industry,2022,51(4):1174-1180+ 1201(in Chinese).㊀第5期李雪礼等:常压无氯盐溶液制备α-CaSO4㊃0.5H2O晶体研究863㊀[7]㊀梁现红,谭㊀琦,张传祥,等.大长径比硫酸钙晶须的制备及形貌研究[J].矿产保护与利用,2017(6):87-92+96.LIANG X H,TAN Q,ZHANG C X,et al.Study on the preparation and morphology of large aspect ratio calcium sulfate whisker[J].Conservation and Utilization of Mineral Resources,2017(6):87-92+96(in Chinese).[8]㊀刘存成,贺方杰,孙顺平,等.常压酸化法从磷钾伴生矿酸浸液中制备硫酸钙晶须[J].化学研究,2017,28(4):432-438.LIU C C,HE F J,SUN S P,et al.Preparation of calcium sulfate whisker from acid-leaching solution of phosphate-potassium associated ore by atmospheric acidification method[J].Chemical Research,2017,28(4):432-438(in Chinese).[9]㊀徐㊀伟,李㊀梅,张栋梁,等.稀土石膏常压酸化法制备硫酸钙晶须的研究[J].无机盐工业,2020,52(8):66-71.XU W,LI M,ZHANG D L,et al.Study on preparation of calcium sulfate whisker by atmospheric pressure acidification using rare earth gypsum[J].Inorganic Chemicals Industry,2020,52(8):66-71(in Chinese).[10]㊀ZHANG Y Q,WANG D,ZHANG L L,et al.Facile preparation ofα-calcium sulfate hemihydrate with low aspect ratio using high-gravity reactiveprecipitation combined with a salt solution method at atmospheric pressure[J].Industrial&Engineering Chemistry Research,2017,56(47): 14053-14059.[11]㊀谢㊀晴,蒋美雪,彭同江,等.磷石膏常压酸化法制备无水硫酸钙晶须的实验研究[J].人工晶体学报,2019,48(6):1060-1066+1071.㊀XIE Q,JIANG M X,PENG T J,et al.Experimental study on preparation of anhydrous calcium sulfate whisker by phosphogypsum at atmospheric acidification method[J].Journal of Synthetic Crystals,2019,48(6):1060-1066+1071(in Chinese).[12]㊀MA B G,LU W D,SU Y,et al.Synthesis ofα-hemihydrate gypsum from cleaner phosphogypsum[J].Journal of Cleaner Production,2018,195:396-405.。

不同酶消化法提取猪原代肝细胞的效果比较

不同酶消化法提取猪原代肝细胞的效果比较

532024.4·试验研究0 引言猪圆环病毒(PCV )是Circoviridae 科Circovirus 属的一种无囊膜的单链环状DNA 病毒。

在已知的4个血清型中,PCV2为猪易感的致病性病毒[1]。

PCV2感染会诱导宿主免疫抑制引起猪圆环病毒病(PCVD ),包括断奶仔猪多系统衰竭综合征、新生仔猪先天性脑震颤、皮炎与肾病综合征、猪呼吸道病综合征、母猪繁殖障碍等,给全世界养猪业带来较大的经济损失,是世界各国的兽医与养猪业者公认的造成重大影响的猪传染病[2]。

PCV2的感染在猪生长发育的不同阶段有不同的组织嗜性。

但无论是胎儿阶段还是出生后,肝细胞都是PCV2感染和复制的靶细胞。

因此,PCV2也被视为一种能够诱导猪肝炎的病毒[3]。

且PCV2诱导的肝细胞凋亡在PCV2引发的相关病变和疾病的发病机制中具有关键性作用[4]。

因此,方便、快捷地获取大量有活性的猪肝细胞对于研究PCVD 的致病机制具有重大意义。

目前获取肝细胞常用的方法主要包括机械分离细胞法、非酶分离细胞法、离体酶消化法和酶灌流法等[5]。

因此,本试验采用简便、经济、无需特殊设备、仅需部分肝组织的离体酶消化法,比较不同酶消化分离猪原代肝细胞的效果,为一般实验室提取分离大量有活性的猪肝细胞提供参考。

1 材料与方法1.1 材料1.1.1 主要试剂新鲜猪肝组织,Hank's 平衡盐溶液(HBSS ),磷酸盐缓冲液(无菌PBS ),4%多聚甲醛(PFA ),收稿日期:2024-01-27基金项目:国家自然科学基金项目:复杂器官与组织在脾脏内的功能性再生(32230056)作者简介:周徐倩(1999-),女,汉族,浙江温州人,硕士在读,研究方向:组织工程与再生医学。

*通信作者简介:董磊(1978-),男,汉族,安徽阜阳人,博士,教授,研究方向:组织工程与再生医学、生物材料。

周徐倩,董磊.不同酶消化法提取猪原代肝细胞的效果比较[J].现代畜牧科技,2024,107(4):53-55. doi :10.19369/ki.2095-9737.2024.04.014. ZHOU Xuqian ,DONG Lei .Comparison of the Effect of Different Enzyme Digestion Methods on Extraction of Porcine Primary Hepatocytes[J].Modern Animal Husbandry Science & Technology ,2024,107(4):53-55.不同酶消化法提取猪原代肝细胞的效果比较周徐倩,董磊*(南京大学,江苏 南京 210023)摘要:猪肝细胞是猪圆环病毒的靶细胞,简单快速地提取猪原代肝细胞对于研究猪圆环病毒病的致病机制具有重要意义。

世界卫生组织儿童标准处方集

世界卫生组织儿童标准处方集

WHO Model Formulary for ChildrenBased on the Second Model List of Essential Medicines for Children 2009世界卫生组织儿童标准处方集基于2009年儿童基本用药的第二个标准目录WHO Library Cataloguing-in-Publication Data:WHO model formulary for children 2010.Based on the second model list of essential medicines for children 2009.1.Essential drugs.2.Formularies.3.Pharmaceutical preparations.4.Child.5.Drug utilization. I.World Health Organization.ISBN 978 92 4 159932 0 (NLM classification: QV 55)世界卫生组织实验室出版数据目录:世界卫生组织儿童标准处方集基于2009年儿童基本用药的第二个标准处方集1.基本药物 2.处方一览表 3.药品制备 4儿童 5.药物ISBN 978 92 4 159932 0 (美国国立医学图书馆分类:QV55)World Health Organization 2010All rights reserved. Publications of the World Health Organization can be obtained fromWHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: ******************). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the aboveaddress(fax:+41227914806;e-mail:*******************).世界卫生组织2010版权所有。

2024年上半年肥料产品登记情况和趋势

2024年上半年肥料产品登记情况和趋势

直接审批产品
评审审批产品
600 524
20
18
18
500
16
15
14
400 392
12
10
300
8
6
2001884Fra bibliotek22
100
0
27
16
4
1
0
2023年度微生物肥料产品登记情况
直接审批产品
评审审批产品
250 200 191597
210 189
16 14
14
12
150 125
100
94
59
10
9
8
8
6
张,占比67.0%。
2024上半年肥料登记情况及趋势
★ 根据农业农村部官网公布的数据统计,截止到2024年6月底,在有效期内的化学肥料登记证共 310张,由境内外191家生产企业持有。
2024上半年肥料登记情况及趋势
★ 2024上半年化学肥料直接审批产品中含氨基酸水溶肥料和含腐植酸水溶肥料登记数量相对较 多,含硅水溶肥料和非水溶中量元素肥料较少;
2024上半年肥料登记情况及趋势
★ 2024上半年登记的化学肥 料产品中共涉及40种登记 作物。其中,登记的瓜果蔬 菜类作物居多,其次是大田 类作物。
2024上半年肥料登记情况及趋势
★ 共27张化学肥料登记证,由境外19家企业持有。 ★ 其中,Algas Marinas,S.A.de C.V. 获批2张有机水溶
800 600 400 200
0
1774 2019年
1761 2020年
937 2021年
594 2022年
772 2023年

氟氯苯菊酯对动物的安全数据报告

氟氯苯菊酯对动物的安全数据报告

92%氟氯苯菊酯原药【英文名称】:flumethrin【化学名称】:α-氰基-4-氟-3-苯氧基苄基-3-(β,4-二氯苯乙烯基)-2,2-二甲基环丙烷羧酸酯【化学结构式】:【分子式】:C28H22Cl2FNO3【分子量】:510.4【CAS登记号】:[69770-45-2]【理化性质】:纯品为淡黄色高粘稠油状液体。

沸点:>250℃。

密度:1.013,蒸汽压:1.33×10-8Pa(20℃)。

溶解性:不溶于水,可溶于甲醇、丙酮、二甲苯等有机溶剂。

稳定性:常温下贮存两年无变化。

对动物皮肤和黏膜无刺激作用【用途】:本品为内吸性杀虫剂,高效安全,适用于禽畜体外寄生虫的防治,并有抑制成虫产卵和抑制孵化的活性,但无击倒作用。

本品的一个异构体(反式-ZI)对微小牛蜱的Malchi品系具有异乎寻常的毒力,比当代最高效的拟除虫菊酯如顺式氯氰菊酯和溴氰菊酯的毒力高50倍,这可能是本品能用浇泼法成功地防治蜱类的一个原因,能用于多种蜱、虱和鸡羽螨等。

【规格】:92%TC。

欧洲药物评估机构兽药信息技术单位兽药产品委员会氟氯苯菊酯氟氯苯菊酯是一种用在牛羊身上的菊酯类体外杀虫剂,用作1%浇泼剂(约75%液体石蜡,10% 2-辛基月桂醇,0.5%溶剂油150)或者药浴剂(6%氟氯苯菊酯,73%溶剂油200,3%溶剂油150,其余为乳化剂),主要用来防治跳蚤、蜱和螨。

浇泼剂一般的用量是2mg/kg, 药浴的比例是用1升的产品放在900升水中。

为了防治蚧螨,羊必须浸在水中达到1分钟以上。

用3.6mg氟氯苯菊酯涂在塑料条上,挂在蜂箱里用来防治蜂螨,一般成蜂蜂箱挂4条,幼蜂蜂箱挂2条。

氟氯苯菊酯是一种Ⅱ型人工合成菊酯,可以引起神经细胞钠离子渗透性增强,使本来短暂的钠离子反应持续延长,导致对细胞伤害增加。

苯氧基-氟苄酯的a-氰基被认为是导致钠离子渗透性增强的主要原因。

利用剂量为1mg/kg的氟氯苯菊酯对几组白鼠进行口服试验,并利用C14-[Cl]进行标记,结果显示在24小时之内有68%的成分通过粪便排出体外,2%通过尿液排出。

二氟尼柳美国药典

二氟尼柳美国药典

Diflunisal Tablets» Diflunisal Tablets contain not less than 90.0 percent and not more than 110.0 percent of the labeled amount of C13H8F2O3.Packaging and storage— Preserve in well-closed containers.USP Reference standards 11—USP Diflunisal RS.Identification—A: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that of the Standard preparation, obtained as directed in the Assay.B: Transfer a quantity of finely ground Tablets, equivalent to about 100 mg of diflunisal, to a 10-mL volumetric flask, add 2 mL of water, and sonicate for 5 minutes. Dilute with methanol to volume, sonicate for an additional 5 minutes, mix, and filter. Separately apply 10 µL each of the filtrate and a Standard solution of USP Diflunisal RS in methanol solution (4 in 5) containing 10 mg per mL to a thin-layer chromatographic plate (see Chromatography 62) coated with a 0.25-mm layer of chromatographic silica gel mixture.Develop the chromatogram in a solvent system consisting of n-hexane, glacial acetic acid, and chloroform (17:3:2) until the solvent front has moved aboutthree-fourths of the length of the plate. Remove the plate from the chamber, air-dry, and examine under long-wavelength UV light: the RF value of the principal spot in the chromatogram of the test solution corresponds to that obtained from the Standard solution.Dissolution 71—pH 7.20, 0.1 M Tris buffer— Dissolve 121 g of tris (hydroxymethyl) aminome thane (THAM) in 9 liters of water. Adjust the solution with a 7 in 100 solution of anhydrous citric acid in water to a pH of 7.45, at 25. Dliters, equilibrate to 37, a H of 7.20, if necessary.Medium: pH 7.20, 0.1 M Tris buffer; 900 mL.Apparatus 2: 50 rpm.Time: 30 minutes.Procedure— Determine the amount of C13H8F2O3 dissolved from UV absorbances at the wavelength of maximum absorbance at about 306 nm of filtered portions of the solution under test, suitably diluted with pH 7.20, 0.1 M Tris buffer, in comparison with a Standard solution having a known concentration of USP Diflunisal RS in the same Medium.Tolerances— Not less than 80% (Q) of the labeled amount of C13H8F2O3 is dissolved in 30 minutes.Uniformity of dosage units 90: mProcedure for content uniformity—Transfer 1 finely powdered Tablet to a200-mL volumetric flask, add 50 mL of water, shake by mechanical means for 30 minutes, and sonicate for 2 minutes. Add 100 mL of alcohol to the flask, shake by mechanical means for 15 minutes, and sonicate for 2 minutes. Dilute with alcohol to volume, mix, and centrifuge a portion of the solution. Quantitatively dilute an accurately measured volume of the resultant clear supernatant with alcohol, if necessary, to obtain a test solution containing about 1.25 mg per mL. Transfer about 125 mg of USP Diflunisal RS, accurately weighed, to a 100-mL volumetric flask, add 75 mL of alcohol to dissolve, dilute with water to volume, and mix to obtain the Standard solution. Transfer 3.0 mL each of the Standard solution and the test solution to separate 50-mL volumetric flasks. To each flask add 5.0 mL of a solution containing 1 g of ferric nitrate in 100 mL of 0.08 N nitric acid, dilute with water to volume, and mix. Concomitantly determine the absorbances of the solutions at the wavelength of maximum absorbance at about 550 nm, with a suitable spectrophotometer, using water as the blank. Calculate the quantity, in mg, of C13H8F2O3 in the Tablet by the formula:(TC / D)(AU / AS)in which T is the labeled quantity, in mg, of diflunisal in the Tablet; C is the concentration, in µg per mL, of USP Diflunisal RS in the Standard solution; D is the concentration, in µg per mL, of diflunisal in the test solution, based uponthe labeled quantity per Tablet and the extent of dilution; and AU and AS are the absorbances of the solutions from the test solution and the Standard solution, respectively.Assay—Mobile phase—Prepare a suitable degassed mixture of water, methanol, acetonitrile, and glacial acetic acid (45:40:17:6) such that the retention time of diflunisal is about 8 minutes.Standard preparation— Dissolve a suitable quantity of USP Diflunisal RS in a mixture of acetonitrile and water (60:40) to obtain a solution having a known concentration of about 1.0 mg per mL.Assay preparation—Weigh and finely powder not fewer than 20 Tablets. Transfer an accurately weighed portion of the powder, equivalent to about 100 mg of diflunisal, to a 100-mL volumetric flask containing about 5 mL of water. Sonicate for 5 minutes, add 60.0 mL of acetonitrile, sonicate for an additional 5 minutes, dilute with water to volume, mix, and filter.Chromatographic system (see Chromatography 62)—The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1.The flow rate is about 2.0 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the tailing factor for the analyte peak is not more than 2.0, and the relative standard deviation for replicate injections is not more than 2.0%.Procedure— Separately inject equal volumes (about 20 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of diflunisal (C13H8F2O3) in the portion of Tablets taken by the formula:100C(rU / rS)in which C is the concentration, in mg per mL, of USP Diflunisal RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.。

美国HACCP的指南

美国HACCP的指南

前言“水产品危害及控制指南”是美国食品与药物管理局(FDA)的第三版。

本指南与FDA颁布的最终法规(21 CFR 123)有关,该法规要求水产品的加工者应建立和实施与其生产操作相适应的危害分析与关键控制点(HACCP)体系。

那些最终法规是1995年12月18日正式公布的,并于1997年12月18日生效,法规中制成法典的部分列在附录8中。

FDA打算在获得更新的有关水产品危害和控制资料后每2-3年重新修订和重新出版本指南。

FDA为确认拟定本指南的第四版,决定采纳对此第三版本的公众建议。

建议请寄到:U.S. Food and Drug AdministrationDockets ManagementBranch (HFA-305)Room 1-2312420 Parklawn DriveRockville, MD 20857建议应与概要号93N-195一致。

本指南现在是作为对“危害分析与关键控制点培训教程”的配套文件,它是由海产品HACCP培训和教育联盟制定的。

联盟是联邦和州执法者的组织,包括FDA、研究院和水产品企业。

FDA鼓励水产品的加工者在建立HACCP体系时共同使用这两份材料,培训教程的副本可以从以下获得:Florida Sea GrantIFAS - Extension BookstoreUniversity of FloridaP.O. Box 110011Gainesville, FL 32611-00114目的本指南的首要目的是帮助水产品的生产者制定HACCP计划。

他们能够从本指南中获得帮助他们确定与其产品有关的危害和制定控制措施的信息。

本指南的另一个目的是帮助消费者和大众依照危害和它们的控制判断商业水产品的安全性。

虽然在本指南的内容中包括了许多关于消费者或零售公司的安全操作规范,但本指南并没有详细阐述这两方面内容。

本指南也可作为联邦和州管理官员在评估水产品HACCP计划时使用的工具书。

四氢氯化物铁螯合酶英文缩写

四氢氯化物铁螯合酶英文缩写

四氢氯化物铁螯合酶英文缩写English:"TetrahydrochloroFerrate(III) Iron Complex Enzyme abbreviated as TFC FeCE. This enzyme is a remarkable catalyst in various chemical reactions due to its unique structure and reactivity. TFC FeCE exhibits high selectivity and efficiency in catalyzing specific transformations, making it a valuable tool in organic synthesis and industrial processes. Its ability to perform complex reactions under mild conditions makes it particularly advantageous in green chemistry initiatives, reducing the environmental impact of chemical manufacturing. Moreover, TFC FeCE's stability under a wide range of reaction conditions enhances its utility in diverse applications, from pharmaceuticals to fine chemicals production. Its synthesis and utilization represent a significant area of research, aiming to harness its potential for advancing sustainable chemical processes and biotechnological applications."中文翻译:"四氢氯化物铁螯合酶的英文缩写为TFC FeCE。

二异丙基甲胺盐酸盐 熔点

二异丙基甲胺盐酸盐 熔点

二异丙基甲胺盐酸盐熔点二异丙基甲胺盐酸盐熔点 -- 揭开化学物质的温度之谜在化学领域中,二异丙基甲胺盐酸盐是一种常见而重要的化学物质。

它具有广泛的应用领域,包括医药、农业、能源等多个行业。

其中,二异丙基甲胺盐酸盐的熔点是这一化合物的重要性质之一。

本文将围绕着二异丙基甲胺盐酸盐熔点这一主题,探索其背后所蕴含的深层次信息。

1. 二异丙基甲胺盐酸盐的基本概述二异丙基甲胺盐酸盐是一种有机化合物,其化学式为C6H16NCl。

它是一种无色至淡黄色的液体,有强烈的氨味。

在化学制剂中,二异丙基甲胺盐酸盐被广泛用作还原剂、催化剂以及有机合成的中间体。

它在医药制剂中被用来制备药物如安非他酮等,也可以用于水处理和橡胶加工等工业领域。

2. 二异丙基甲胺盐酸盐的熔点意味着什么?熔点是指物质由固态转变为液态的温度。

对于二异丙基甲胺盐酸盐这一化合物而言,其熔点是衡量其纯度和稳定性的重要指标。

通过测定其熔点,我们可以判断该化合物的结晶状态、纯度和稳定性,进而决定其在不同应用领域中的适用性。

3. 二异丙基甲胺盐酸盐熔点的测定方法为了准确测定二异丙基甲胺盐酸盐的熔点,常用的方法是差热分析法(DSC)和熔点仪法。

其中,差热分析法是一种通过测量物质在升温或降温过程中吸热或放热的差异,来确定其熔点的分析方法。

熔点仪法则是通过观察物质从固态到液态的温度范围,确定其熔点的方法。

4. 二异丙基甲胺盐酸盐熔点与结晶状态的关系通过观察二异丙基甲胺盐酸盐的熔点,我们可以推测出其结晶状态。

对于某些物质而言,熔点与其结晶状态密切相关。

对于纯净的二异丙基甲胺盐酸盐而言,其熔点往往与其理论熔点非常接近,说明其处于完全结晶状态。

而若熔点偏离理论数值,往往意味着样品中可能存在杂质或结晶不完全。

5. 二异丙基甲胺盐酸盐熔点的影响因素二异丙基甲胺盐酸盐的熔点受多种因素的影响,包括结晶状态、纯度、环境温度等。

熔点与结晶状态的关系我们已经讨论过,结晶程度越高,熔点越接近理论数值。

茜草素简介

茜草素简介

茜草素简介
目录
•1拼音
•2英文参考
•3注解
1拼音
qiàn cǎo sù
2英文参考
Alizaria
3注解
茜草素是一种蒽醌类化合物,分子式C14H8O4,分子量240.20,斜方橙色针状结晶,熔点290℃。

存在于茜草科植物茜草Rubia cordifolia L.根,羊角藤Morinda umbellata L.的根及根茎中。

实验证明茜草素大剂量能降低动物血压而不影响心脏,有某些利尿及兴奋离体肠管的作用,对金黄色葡萄球菌有抑制作用,可用于测定肾功能、研究骨骼生长、检定及分离细菌及作免疫学研究(抗体吸附剂)等。

此外还有抗肿瘤和免疫抑制作甩。

免责声明:本文内容来源于网络,不保证100%正确,涉及到药方及用法用量的问题,不保证正确,仅供参考。

由此造成的问题,本站概不负责。

亚铁氰化钾MSDS

亚铁氰化钾MSDS




侵入途径:吸入、食入、经皮吸收。
健康危害:本品属低毒类。吸入引起咳嗽、气短。大量口服引起胃肠不适。有资料报道,中毒时肾脏受损害,尿糖大量增加。接触本品多年的工人中,未见发生皮炎。




皮肤接触:脱去污染的衣着,用流动清水冲洗。
眼睛接触:提起眼睑,用流动清水或生理盐水冲洗。就医。
吸入:迅速脱离现场至空气新鲜处。保持呼吸道通畅。如呼吸困难,给输氧。如呼吸停止,立即进行人工呼吸。就医。
起运时包装要完整,装载应稳妥。运输过程中要确保容器不泄漏、不倒塌、不坠落、不损坏。严禁与氧化剂等混装混运。运输途中应防曝晒、雨淋,防高温。




车间卫生标准:前苏联MAC(mg/m3):4
检测方法:
工程控制:生产过程密闭,全面通风。
呼吸系统防护:空气中粉尘浓度较高时,建议佩戴自吸过滤式防尘口罩
眼睛防护:戴化学安全防护眼镜。
食入:迅速脱离现场至空气新鲜处。保持呼吸道通畅。如呼吸困难,给输氧。如呼吸停止,立即进行人工呼吸。就医。
食入:饮足量温水,催吐,用2%~5%硫酸钠溶液洗胃,导泻。就医。







燃烧性:本品不燃。
闪点(℃):无资料。
爆炸下限(%):无资料。
引燃温度(℃):无资料。
爆炸上限(%):无资料。
最小点火能(mJ):无资料。
最大爆炸压力(MPa):无资料
危险特性:与硝酸铜、亚硝酸钠加热时发生爆炸。遇高热分解释出高毒烟气。
灭火方法:尽可能将容器从火场移至空旷处。灭火剂:雾状水、泡沫、干粉、二氧化碳、砂土。

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Dealkylatior The
occurred with 4 and 6 because of the acid lability of their ethereal G-C bonds.' Ferric chloride has been used fo 5 appears decomposition. 4-methoxycinnamate derivative 9 was decomposed by this reagent, presumably by oxidation of the aromatic ring. The stability of other groups was tested. Protecting groups such as acetonidesg and benzylidine acctals are labile to FeC13. The benzoate group was stable, and derivatives 8 and 13 yielded a-glycosides. Thl reactions were, however, slower than the acetate derivative 1. The benzoate derivative of methyl xyloside 1: was sensitive to decomposition presumably due to the greater acid lability of the xylose ring; the correspondin! acetate derivative 11 was less sensitive to decomposition and gave good results. The methyl-protected glycosidl 10 was easily hydrolyzed, yielding the corresponding lactol and glycosyl chloride. The Zdeoxy derivative 11 gave high a-selectivity comparable to the oxygen sugars. Anomerization of the methoxyl group of 15 wa achieved, but the reaction was slow and decomposition products were also obtained; anomerization of the seconr : anomeric center was not observed. The acetate derivative of glucosamine 16 afforded a complex mixture of 0: glycoside and decomposition products resulting from the cleavage of the anomeric methoxyl group; a sohtbilit: problem also arose presumably from the complexation of FeC13 to the basic acetylamino group. Thl bromobenzoate derivative 17 gave better results, but the anomerization was slow and significant amounts of thl bicyclic oxazoline derivative, resulting from the displacement of the anomeric methoxyl group by the C-: aminoacyl carbonyl group, was isolated. Anomerization was attempted with the furanoside derivatives, methy 8-ribofuranoside triacetate and methyl B-fructofuranoside tetrabenzoate, but was unsuccessful. Product resulting from exocyclic bond cleavage were observed, consistent with the greater lability of the glycosidic bonr of furanosides compared to those of pyranosides.10 The anomerization may occur by two pathways, involving endccyclic bond cleavage (Path A) or exocyclil bond cleavage (Path B).ll Path A may predominate for acylated oxygen sugars, since side products resultin! from the exocyclic C-O bond cleavage (lactols and chlorides) are not observed. Path B may be more prcvalen with the nitrogen sugars (16 and 17), which possess the cation-stabilizing C-Z aminoacyl groups.
imp. SM decomp. a
lh lh 15 min 85%
92:8
4.5 h lh Me (10) lactol a 'OR
OBz-Br
89%
92 :8 __ __
20 min
85%
lh lh
83%
89:11 __
4-BrBz (12)
decomp.
0CH3
`OBz-Br
(13)
a
5h
88%
Tcmihedmn Lettax. Vol. 33. No. 30, pp. 4295-4298.1992 Priited in Grest Britain
oo404039/92
$5.00. ,013
Pergamon Press Ltd
Ferric Chloride, an Anomerization Catalyst for the Preparation of Alkyl a-Glycopyranosides
I
OCHB
Thus,
this reagent
offers a simple
route for the preparation
of a-glycopyranosides
from
P-glycopyranosides
or a mixture of a-and P-glycopyranosides.
Ferric chloride is an inexpensive and easilyvarious
The tetra-0-acetyl oxidation of phenol
glucoside derivatives (l-3,7) ethers,8 and the glycoside
gave good yields and
4295
4296
Table I. Anomerization Results:6 A&rPmd
R-
Time
1.5h 45 min Ih 20 min
%Ma
83% 84% 90% 82%
a/B Ratb b
90 : 10
Me (1)
a
94 :6 95:s __ -__
Ph (5) cholesteryl (6) cholestanyl (7)
Anomerically pure glycosides are prepared from glycosyl halides by two strategies1 An acyloxy group a the C-Z position directs the incoming glycopyranosides preparation of 1,2-cis glycopyranosides nucleophile via neighboring group participation to give 1,2-tram (p-glycoside for the &co and galacto series, and a-glycoside is more difficult for the ~URPZD series). The The disadvantages of the
selectivity (a: p cu. 95 : 5)s A mixture of a-and p-glycosides afforded similar results.
BnQ 1. Fe&, OCH ' CH.$$ fl, 1 h RO do R = 4-MeOCinn RO
2.
-
4-MeOCinnCl, AgOTf PY, a 1 h (90%)
Summary:
Anhydrous FeC$ in CHzClz has been found to readily anomerize P-glycopyranosides
to their
corresponding u-anomers in good yields and selectivities at room temperature. Acetyl- and benzoyl-protected oxygen sugars yielded the best results.
相关文档
最新文档